IMP2 supports glycolytic functions in FLT3-ITD-positive acute myeloid leukemia (AML), a common and aggressive form of AML characterized by an internal tandem duplication mutation in the FLT3 gene [101]. The gene discussed is FLT3; the disease is acute myeloid leukemia.